Xoma Corp $3.88

down -0.18


31/7/2014 04:00 PM  |  NASDAQ : XOMA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get XOMA Trend Analysis - it has underperformed the S&P 500 by 42%

Partner Headlines

  1. Morning Market Movers

    Benzinga
  2. UPDATE: MLV & Co Upgrades XOMA on Valuation

    Benzinga
  3. XOMA Finalizes Plans for Gevokizumab Phase 3 Clinical Program in Pyoderma ...

    Benzinga
  4. Benzinga's Top Downgrades

    Benzinga
  5. UPDATE: MLV & Co Downgrades XOMA on Valuation/Sentiment

    Benzinga
  6. Mid-Afternoon Market Update: FuelCell Energy Hangs on to Gains as Canadian ...

    Benzinga
  7. Mid-Day Market Update: Smith & Wesson Surges On Upbeat Results; XOMA Shares ...

    Benzinga
  8. Mid-Morning Market Update: Markets Mostly Flat; Brown-Forman Posts Higher ...

    Benzinga
  9. Morning Lowers for Mar. 5, 2014: XOMA, USU, CSIQ, AUDC, RATE

    Benzinga
  10. Benzinga's Top #PreMarket Losers

    Benzinga
  11. UPDATE: XOMA Offers Update on Gevokizumaba, Says Results Do Not Support ...

    Benzinga
  12. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, XOMA, ...

    Benzinga
  13. Stocks Hitting 52-Week Highs

    Benzinga
  14. Benzinga's Top #PreMarket Losers

    Benzinga
  15. XOMA Announces Closing of the Offering and Exercise of 1.425M Share Over ...

    Benzinga
  16. XOMA Announces Pricing of 9.5M Shares at $5.25 per Share

    Benzinga
  17. XOMA Prices 9.5M Share Offering at $5.25/Share

    Benzinga
  18. Benzinga's Top #PreMarket Losers

    Benzinga
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Xoma Shares Rise 6% After-Hours on Encouraging Phase 2 Gevokizumab Results

    Benzinga
  21. XOMA Shares Quiet Following Results of Two Phase 2 Trials Showing Gevokizumab ...

    Benzinga
  22. UPDATE: Piper Jaffray Initiates XOMA at Overweight on 'Xciting Antibody ...

    Benzinga
  23. Benzinga's Top Initiations

    Benzinga
  24. Benzinga's Top Pre-Market Losers

    Benzinga
  25. UPDATE: Wedbush Raises PT to $5 on Xoma on Gevokizumab Initial Efficacy

    Benzinga
  26. XOMA Says Sevier Initiated Proof-of-Concept Gevokizumab Study for Acute ...

    Benzinga
  27. XOMA Corp (XOMA) CFO & VP Finance Fred Kurland sells 9,111 Shares

    GuruFocus
  28. XOMA Announces Servier Has Initiated Phase 3 Gevokizumab Trial in Patients ...

    Benzinga
  29. UPDATE: XOMA Receives Orphan Drug Designation From FDA for Gevokizumab

    Benzinga
  30. XOMA Ltd. Reports Operating Results (10-Q)

    GuruFocus
  31. CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility; Terms Not ...

    Benzinga
  32. Oncobiologics Announces Agreement To Utilize XOMA's Fully Human Antibody ...

    Benzinga
  33. Health Care Sector Wrap

    FoxBusiness
  34. Benzinga's Top Initiations

    Benzinga
  35. Earnings Scheduled For March 6

    Benzinga
  36. End-of-Day Market Summary for January 17, 2012

    Benzinga
  37. Xoma Shares Down After Job Cuts and One Time Charges Announced

    Benzinga
  38. Benzinga's Microcap Movers for Thursday January 5, 2012

    Benzinga
  39. XOMA Streamlines Operations to Invest in Value-Creating Activities; Cuts ...

    Benzinga
  40. XOMA Corporation New CEO Says Company Expects to Initiate Global Gevokizumab ...

    Benzinga
  41. XOMA Appoints John Varian as Chief Executive Officer

    Benzinga
  42. XOMA Will Move Its Corporate Domicile to Delaware

    Benzinga
  43. XOMA Initiates Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris

    Benzinga
Trading Center